Wenxin Wei

619 total citations
24 papers, 302 citations indexed

About

Wenxin Wei is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Wenxin Wei has authored 24 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Wenxin Wei's work include MicroRNA in disease regulation (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Wenxin Wei is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Wenxin Wei collaborates with scholars based in China, United States and Hong Kong. Wenxin Wei's co-authors include Xinming Qi, Chun‐Zhu Li, Jin Ren, Lei Huo, Ningyang Jia, Zhengqing Lei, Yu Li, Lingling Miao, Hong Yan and Jing Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Wenxin Wei

22 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenxin Wei China 10 148 113 75 73 61 24 302
Hiroki Teraoku Japan 13 116 0.8× 73 0.6× 97 1.3× 107 1.5× 96 1.6× 44 352
Yamin Zhang China 12 116 0.8× 58 0.5× 82 1.1× 57 0.8× 116 1.9× 37 339
Haigang Geng China 7 140 0.9× 74 0.7× 57 0.8× 72 1.0× 32 0.5× 20 311
Minekazu Yamaguchi Japan 6 173 1.2× 145 1.3× 225 3.0× 62 0.8× 44 0.7× 10 371
Fudong Lv China 9 159 1.1× 102 0.9× 84 1.1× 92 1.3× 44 0.7× 13 312
Zhili Wen China 8 166 1.1× 103 0.9× 77 1.0× 38 0.5× 35 0.6× 25 289
Ram C. Shankaraiah Italy 10 188 1.3× 147 1.3× 39 0.5× 95 1.3× 17 0.3× 11 339
Xiangbin Wan China 10 134 0.9× 100 0.9× 40 0.5× 122 1.7× 84 1.4× 24 327
P. Merle United States 3 95 0.6× 79 0.7× 195 2.6× 60 0.8× 60 1.0× 5 333
Yunhong Tian China 10 123 0.8× 77 0.7× 32 0.4× 106 1.5× 77 1.3× 29 307

Countries citing papers authored by Wenxin Wei

Since Specialization
Citations

This map shows the geographic impact of Wenxin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxin Wei more than expected).

Fields of papers citing papers by Wenxin Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxin Wei. The network helps show where Wenxin Wei may publish in the future.

Co-authorship network of co-authors of Wenxin Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxin Wei. A scholar is included among the top collaborators of Wenxin Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxin Wei. Wenxin Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Liu, Chenjing, Guoping Li, Yujing Gao, et al.. (2024). Recyclable selenoviologen-based D-A porous ionic polymer: from dual-channels photocatalytic degradation to plant growth. Science China Chemistry. 68(4). 1511–1521. 3 indexed citations
4.
Wei, Wenxin, Qiuhong Man, Liang Chen, et al.. (2023). Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma. Cancer Letters. 578. 216442–216442. 24 indexed citations
5.
Gao, Chao, et al.. (2022). Thyroidectomy Using the Lateral Cervical Small Incision Approach for Early Thyroid Cancer. Clinical Cosmetic and Investigational Dermatology. Volume 15. 713–720. 2 indexed citations
6.
Zhao, Huan, et al.. (2022). High expression of aurora kinase B predicts poor prognosis in hepatocellular carcinoma after curative surgery and its effects on the tumor microenvironment. Annals of Translational Medicine. 10(21). 1168–1168. 9 indexed citations
7.
Gao, Chao, et al.. (2022). The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer. Bioengineered. 13(4). 9097–9105. 6 indexed citations
8.
Zhang, Ling, Xian Yu, Wenxin Wei, et al.. (2020). Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology. European Radiology. 30(10). 5327–5336. 49 indexed citations
9.
Aung, Thazin Nwe, Saeed Nourmohammadi, Zhipeng Qu, et al.. (2019). Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle. Scientific Reports. 9(1). 14200–14200. 11 indexed citations
10.
11.
Huo, Lei, Wenxin Wei, Zhenlin Yan, et al.. (2019). Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus. Cell & Bioscience. 9(1). 23–23. 21 indexed citations
12.
Wei, Wenxin & Hua Mei. (2018). Research progress of relationship between miRNA and neonatal lung injury. International journal of pediatrics. 45(7). 520–523. 1 indexed citations
13.
Wei, Wenxin, Zhishi Yang, Jun Li, et al.. (2018). Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma. International Journal of Surgery. 56. 256–263. 9 indexed citations
14.
Wei, Wenxin, et al.. (2018). The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 3(1). 3–3. 27 indexed citations
15.
Cui, Yong, Xiaojun Wu, Jian Li, et al.. (2018). Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray. Oncology Reports. 39(5). 2333–2341. 9 indexed citations
16.
Hou, Ying, Hongjun Xiang, Xianxiu Wan, et al.. (2017). Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma. Oncogenesis. 6(7). e362–e362. 16 indexed citations
17.
Qi, Xinming, Jing Chen, Wenxin Wei, et al.. (2017). The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma. Cancer Letters. 408. 102–111. 63 indexed citations
18.
He, Jian, Liang Liu, Dujin Wang, et al.. (2017). Targeting of AUF1 to vascular endothelial cells as a novel anti-aging therapy.. PubMed. 14(8). 515–523. 10 indexed citations
20.
Papachristou, G., et al.. (2011). Efficacy & Complications Of ExPress Mini Shunt Surgery For Uncontrolled Glaucoma. Investigative Ophthalmology & Visual Science. 52(14). 2635–2635. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026